Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Journal of Cardiovascular Pharmacology
|
April 1, 1993
Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis
C V Jackson, H C Wilson, V G Growe, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis
C V Jackson, J D Frank, T J Craft, et al.
Diabetes
|
September 1, 1985
A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy
C V Jackson, G M McGrath, A G Tahiliani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1992
Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis
C V Jackson, V G Crowe, J D Frank, et al.
Circulation
|
September 1, 1990
Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis
C V Jackson, V G Crowe, T J Craft, et al.
Chest
|
August 1, 1989
Utility of the Wang 18-gauge transbronchial histology needle in the staging of bronchogenic carcinoma
D A Schenk, P J Strollo, J S Pickard, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1996
A family of arginal thrombin inhibitors related to efegatran
G F Smith, R T Shuman, T J Craft, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Journal of Cardiovascular Pharmacology
|
April 1, 1993
Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis
C V Jackson, H C Wilson, V G Growe, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis
C V Jackson, J D Frank, T J Craft, et al.
Diabetes
|
September 1, 1985
A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy
C V Jackson, G M McGrath, A G Tahiliani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1992
Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis
C V Jackson, V G Crowe, J D Frank, et al.
Circulation
|
September 1, 1990
Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis
C V Jackson, V G Crowe, T J Craft, et al.
Chest
|
August 1, 1989
Utility of the Wang 18-gauge transbronchial histology needle in the staging of bronchogenic carcinoma
D A Schenk, P J Strollo, J S Pickard, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1996
A family of arginal thrombin inhibitors related to efegatran
G F Smith, R T Shuman, T J Craft, et al.
Page
of 3